Bicara Therapeutics Inc.(BCAX)
$10.53+0.35 (+3.44%)
BCAX
Bicara Therapeutics Inc. financials statements
$10.53
At close:+0.35 (+3.44%)
Want to see BCAX full AI Analyst Report?
Bicara Therapeutics Inc. (BCAX) Ratios
92 Followers
Bicara Therapeutics Inc. Ratios
BCAX's free cash flow for Q3 2026 was $-56.79M. For the 2026 fiscal year, BCAX's free cash flow was decreased by $-663.00K and operating cash flow was $-56.13M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 |
|---|---|---|---|---|
| Liquidity Ratios | ||||
| Current Ratio | 14.58 | 27.93 | 15.32 | 0.21 |
| Quick Ratio | 14.58 | 27.93 | 15.32 | 0.21 |
| Cash Ratio | 3.34 | 27.22 | 15.28 | 0.17 |
| Solvency Ratio | -4.67 | -0.88 | -3.36 | -1.58 |
| Operating Cash Flow Ratio | -3.69 | -4.16 | -3.02 | -1.34 |
| Short-Term Operating Cash Flow Coverage | 0.00 | -123.15 | 0.00 | 0.00 |
| Net Current Asset Value | $ 392.51M | $ 425.21M | $ 215.60M | $ -19.00M |
| Leverage Ratios | ||||
| Debt-to-Assets Ratio | 0.00 | 0.00 | 0.00 | 0.00 |
| Debt-to-Equity Ratio | 0.00 | 0.00 | 0.00 | 0.00 |
| Debt-to-Capital Ratio | 0.00 | 0.00 | 0.00 | 0.00 |
| Long-Term Debt-to-Capital Ratio | 0.00 | 0.00 | 0.00 | 0.00 |
| Financial Leverage Ratio | 1.07 | 1.16 | 1.07 | -0.39 |
| Debt Service Coverage Ratio | 0.00 | -111.93 | 0.00 | -336.81 |
| Interest Coverage Ratio | 0.00 | 0.00 | 0.00 | -336.21 |
| Debt to Market Cap | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Debt Per Share | 0.03 | 0.01 | 0.01 | 0.00 |
| Net Debt to EBITDA | 0.69 | 7.22 | 5.76 | 0.11 |
| Profitability Margins | ||||
| Gross Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% |
| EBIT Margin | 0.00% | 0.00% | 0.00% | 0.00% |
| EBITDA Margin | 0.00% | 0.00% | 0.00% | 0.00% |
| Operating Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% |
| Pretax Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% |
| Net Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% |
| Continuous Operations Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% |
| Net Income Per EBT | 100.16% | 100.28% | 100.01% | 100.00% |
| EBT Per EBIT | 88.52% | 82.30% | 130.31% | 100.50% |
| Return on Assets (ROA) | -32.01% | -11.95% | -22.22% | -564.60% |
| Return on Equity (ROE) | -34.36% | -13.82% | -23.79% | 219.04% |
| Return on Capital Employed (ROCE) | -38.70% | -14.95% | -18.22% | 219.02% |
| Return on Invested Capital (ROIC) | -38.60% | -14.93% | -18.20% | 219.02% |
| Return on Tangible Assets | -32.01% | -11.95% | -22.22% | -564.60% |
| Earnings Yield | -14.99% | -7.17% | -4.29% | -3.12% |
| Efficiency Ratios | ||||
| Receivables Turnover | 0.00 | 0.00 | 0.00 | 0.00 |
| Payables Turnover | 0.00 | 0.00 | 0.00 | 0.00 |
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 |
| Fixed Asset Turnover | 0.00 | 0.00 | 0.00 | 0.00 |
| Asset Turnover | 0.00 | 0.00 | 0.00 | 0.00 |
| Working Capital Turnover Ratio | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | 0.00 | 0.00 | 0.00 | 0.00 |
| Days of Sales Outstanding | 0.00 | 0.00 | 0.00 | 0.00 |
| Days of Inventory Outstanding | 0.00 | 0.00 | 0.00 | 0.00 |
| Days of Payables Outstanding | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Cycle | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Flow Ratios | ||||
| Operating Cash Flow Per Share | -1.95 | -1.37 | -0.88 | -0.62 |
| Free Cash Flow Per Share | -1.96 | -1.37 | -0.89 | -0.62 |
| Dividend Paid and CapEx Coverage Ratio | -381.55 | -1052.83 | -77.86 | -167.06 |
| Capital Expenditure Coverage Ratio | -381.55 | -1052.83 | -77.86 | -167.06 |
| Operating Cash Flow Coverage Ratio | -62.48 | -101.29 | -69.45 | 0.00 |
| Operating Cash Flow to Sales Ratio | 0.00 | 0.00 | 0.00 | 0.00 |
| Free Cash Flow Yield | -11.64% | -7.89% | -3.81% | -2.66% |
| Valuation Ratios | ||||
| Price-to-Earnings (P/E) Ratio | -6.68 | -13.94 | -23.31 | -32.02 |
| Price-to-Sales (P/S) Ratio | 0.00 | 0.00 | 0.00 | 0.00 |
| Price-to-Book (P/B) Ratio | 2.29 | 1.93 | 5.55 | -70.13 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -8.59 | -12.67 | -26.22 | -37.55 |
| Price-to-Operating Cash Flow Ratio | -8.61 | -12.68 | -26.56 | -37.78 |
| Price-to-Earnings Growth (PEG) Ratio | -0.07 | -0.56 | -0.63 | 0.00 |
| Enterprise Value Multiple | -6.00 | -6.78 | -24.63 | -32.01 |
| Enterprise Value | 825.24M | 459.11M | 981.94M | 1.21B |
| EV to EBITDA | -6.00 | -6.78 | -24.63 | -32.01 |
| EV to Sales | 0.00 | 0.00 | 0.00 | 0.00 |
| EV to Free Cash Flow | -7.70 | -6.14 | -21.25 | -37.42 |
| EV to Operating Cash Flow | -7.72 | -6.14 | -21.52 | -37.65 |
| Tangible Book Value Per Share | 7.34 | 9.04 | 4.22 | -0.33 |
| Shareholders’ Equity Per Share | 7.34 | 9.04 | 4.22 | -0.33 |
| Tax and Other Ratios | ||||
| Effective Tax Rate | -0.00 | -0.00 | -0.00 | -0.00 |
| Revenue Per Share | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income Per Share | -2.52 | -1.25 | -1.00 | -0.73 |
| Tax Burden | 1.00 | 1.00 | 1.00 | 1.00 |
| Interest Burden | 1.00 | 1.00 | 1.30 | 1.00 |
| Research & Development to Revenue | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A to Revenue | 0.00 | 0.00 | 0.00 | 0.00 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Quality | 0.77 | 1.10 | 0.88 | 0.85 |
Currency in USD
